Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
Pettorruso M, Guidotti R, d'Andrea G, De Risio L, D'Andrea A, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, De Filippis S, Di Nicola M, Andriola I, Marcatili M, Nicolò G, Martiadis V, Bassetti R, Nucifora D, De Fazio P, Rosenblat JD, Clerici M, Maria Dell'Osso B, Vita A, Marzetti L, Sensi SL, Di Lorenzo G, McIntyre RS, Martinotti G; REAL-ESK Study Group. Pettorruso M, et al. Among authors: andriola i. Psychiatry Res. 2023 Sep;327:115378. doi: 10.1016/j.psychres.2023.115378. Epub 2023 Jul 28. Psychiatry Res. 2023. PMID: 37574600 Free article.
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses.
Rocca P, Galderisi S, Rossi A, Bertolino A, Rucci P, Gibertoni D, Montemagni C, Bellino S, Aguglia E, Amore M, Bellomo A, Biondi M, Carpiniello B, Cuomo A, D'Ambrosio E, dell'Osso L, Girardi P, Marchesi C, Monteleone P, Montemitro C, Oldani L, Pacitti F, Roncone R, Siracusano A, Tenconi E, Vita A, Zeppegno P, Steardo L Jr, Vignapiano A, Maj M; Members of the Italian Network for Research on Psychoses include. Rocca P, et al. Schizophr Res. 2018 Nov;201:105-112. doi: 10.1016/j.schres.2018.06.003. Epub 2018 Jun 10. Schizophr Res. 2018. PMID: 29898819 Free article.
Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics.
Rampino A, Torretta S, Gelao B, Veneziani F, Iacoviello M, Marakhovskaya A, Masellis R, Andriola I, Sportelli L, Pergola G, Minelli A, Magri C, Gennarelli M, Vita A, Beaulieu JM, Bertolino A, Blasi G. Rampino A, et al. Among authors: andriola i. Eur Psychiatry. 2021 Apr 19;64(1):e39. doi: 10.1192/j.eurpsy.2021.26. Eur Psychiatry. 2021. PMID: 33866994 Free PMC article.
How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention.
Luciano M, Sampogna G, Amore M, Andriola I, Calcagno P, Carmassi C, Del Vecchio V, Dell'Osso L, Di Lorenzo G, Gelao B, Giallonardo V, Rossi A, Rossi R, Siracusano A, Fiorillo A; LIFESTYLE Working Group. Luciano M, et al. Among authors: andriola i. Eur Psychiatry. 2021 Nov 23;64(1):e72. doi: 10.1192/j.eurpsy.2021.2253. Eur Psychiatry. 2021. PMID: 34812136 Free PMC article. Clinical Trial.
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study.
Monteleone P, Cascino G, Rossi A, Rocca P, Bertolino A, Aguglia E, Amore M, Andriola I, Bellomo A, Biondi M, Brasso C, Carpiniello B, Collantoni E, Dell'Osso L, di Giannantonio M, Fabrazzo M, Fagiolini A, Giordano GM, Marcatili M, Marchesi C, Monteleone AM, Pompili M, Roncone R, Siracusano A, Vita A, Zeppegno P, Galderisi S, Maj M; Italian Network for Research on Psychoses. Monteleone P, et al. Among authors: andriola i. Schizophr Res. 2022 Oct;248:279-286. doi: 10.1016/j.schres.2022.08.015. Epub 2022 Sep 15. Schizophr Res. 2022. PMID: 36116319
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study).
Martinotti G, Vita A, Fagiolini A, Maina G, Bertolino A, Dell'Osso B, Siracusano A, Clerici M, Bellomo A, Sani G, d'Andrea G, Chiaie RD, Conca A, Barlati S, Di Lorenzo G, De Fazio P, De Filippis S, Nicolò G, Rosso G, Valchera A, Nucifora D, Di Mauro S, Bassetti R, Martiadis V, Olivola M, Belletti S, Andriola I, Di Nicola M, Pettorruso M, McIntyre RS, di Giannantonio M; REAL-ESK Study Group. Martinotti G, et al. Among authors: andriola i. J Affect Disord. 2022 Dec 15;319:646-654. doi: 10.1016/j.jad.2022.09.043. Epub 2022 Sep 24. J Affect Disord. 2022. PMID: 36167246
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses.
Rocca P, Rucci P, Montemagni C, Rossi A, Bertolino A, Aguglia E, Altamura CA, Amore M, Andriola I, Bellomo A, Brasso C, Carpiniello B, Del Favero E, Dell'Osso L, Di Fabio F, Fabrazzo M, Fagiolini A, Giordano GM, Marchesi C, Martinotti G, Monteleone P, Pompili M, Roncone R, Rossi R, Siracusano A, Tenconi E, Vita A, Zeppegno P, Galderisi S, Maj M; Italian Network for Research on Psychoses. Rocca P, et al. Among authors: andriola i. Eur Psychiatry. 2023 Jan 11;66(1):e10. doi: 10.1192/j.eurpsy.2022.2356. Eur Psychiatry. 2023. PMID: 36628577 Free PMC article.
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G, Dell'Osso B, Di Lorenzo G, Maina G, Bertolino A, Clerici M, Barlati S, Rosso G, Di Nicola M, Marcatili M, d'Andrea G, Cavallotto C, Chiappini S, De Filippis S, Nicolò G, De Fazio P, Andriola I, Zanardi R, Nucifora D, Di Mauro S, Bassetti R, Pettorruso M, McIntyre RS, Sensi SL, di Giannantonio M, Vita A; REAL-ESK Study Group. Martinotti G, et al. Among authors: andriola i. Bipolar Disord. 2023 May;25(3):233-244. doi: 10.1111/bdi.13296. Epub 2023 Jan 18. Bipolar Disord. 2023. PMID: 36636839 Free article.
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
Chiappini S, d'Andrea G, De Filippis S, Di Nicola M, Andriola I, Bassetti R, Barlati S, Pettorruso M, Sensi S, Clerici M, Dell'Osso B, Vita A, Martinotti G. Chiappini S, et al. Among authors: andriola i. Eur Neuropsychopharmacol. 2023 Sep;74:15-21. doi: 10.1016/j.euroneuro.2023.04.011. Epub 2023 May 4. Eur Neuropsychopharmacol. 2023. PMID: 37148637 Free article.
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group.
d'Andrea G, Chiappini S, McIntyre RS, Stefanelli G, Carullo R, Andriola I, Zanardi R, Martiadis V, Sensi SL, Sani G, Clerici M, Di Lorenzo G, Vita A, Pettorruso M, Martinotti G. d'Andrea G, et al. Among authors: andriola i. Am J Geriatr Psychiatry. 2023 Dec;31(12):1032-1041. doi: 10.1016/j.jagp.2023.06.016. Epub 2023 Jul 8. Am J Geriatr Psychiatry. 2023. PMID: 37479669 Free article.
42 results